Colin Graydon

938 total citations
13 papers, 728 citations indexed

About

Colin Graydon is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Colin Graydon has authored 13 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Colin Graydon's work include Pulmonary Hypertension Research and Treatments (6 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). Colin Graydon is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). Colin Graydon collaborates with scholars based in Canada, Kenya and Germany. Colin Graydon's co-authors include Keith R. Fowke, Steeve Provencher, Sébastien Bonnet, François Potus, Ève Tremblay, Sandra Breuils‐Bonnet, Evangelos D. Michelakis, Roxane Paulin, Jolyane Meloche and Aude Pflieger and has published in prestigious journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and Annals of Surgery.

In The Last Decade

Colin Graydon

13 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Graydon Canada 9 418 268 198 189 156 13 728
Wen Peng China 17 206 0.5× 475 1.8× 105 0.5× 384 2.0× 104 0.7× 36 745
Lingzhi Hong United States 12 238 0.6× 213 0.8× 56 0.3× 115 0.6× 216 1.4× 28 487
Qiying Chen China 14 98 0.2× 448 1.7× 111 0.6× 274 1.4× 51 0.3× 29 689
Davide Germano Switzerland 7 74 0.2× 188 0.7× 150 0.8× 75 0.4× 229 1.5× 10 553
Hiroshi Hongo Japan 13 274 0.7× 169 0.6× 50 0.3× 108 0.6× 119 0.8× 74 511
Stephanie Brandal United States 13 170 0.4× 144 0.5× 92 0.5× 76 0.4× 19 0.1× 31 419
Sook-Whan Sung South Korea 15 492 1.2× 169 0.6× 29 0.1× 86 0.5× 214 1.4× 26 763
Katharina Sinn Austria 12 257 0.6× 131 0.5× 32 0.2× 77 0.4× 72 0.5× 31 526
Stephen Raskin Israel 10 84 0.2× 243 0.9× 66 0.3× 146 0.8× 157 1.0× 31 607
José A. López United States 10 73 0.2× 161 0.6× 116 0.6× 41 0.2× 63 0.4× 19 500

Countries citing papers authored by Colin Graydon

Since Specialization
Citations

This map shows the geographic impact of Colin Graydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Graydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Graydon more than expected).

Fields of papers citing papers by Colin Graydon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Graydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Graydon. The network helps show where Colin Graydon may publish in the future.

Co-authorship network of co-authors of Colin Graydon

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Graydon. A scholar is included among the top collaborators of Colin Graydon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Graydon. Colin Graydon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Graydon, Colin, et al.. (2024). Comparative analysis of LAG3 antibodies shows differential binding patterns by flow cytometry. Journal of Immunological Methods. 534. 113757–113757. 1 indexed citations
2.
Graydon, Colin, et al.. (2023). The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function. Scientific Reports. 13(1). 10082–10082. 8 indexed citations
3.
Graydon, Colin, et al.. (2021). LAG3’s Enigmatic Mechanism of Action. Frontiers in Immunology. 11. 615317–615317. 129 indexed citations
4.
Graydon, Colin, et al.. (2021). Novel in vitro invariant natural killer T cell functional assays. Journal of Immunological Methods. 499. 113171–113171. 2 indexed citations
5.
Graydon, Colin, et al.. (2019). Roles, function and relevance of LAG3 in HIV infection. PLoS Pathogens. 15(1). e1007429–e1007429. 31 indexed citations
6.
Wagner, Richard, et al.. (2019). Strategies to Increase Productivity, Improve Performance, and Decrease Stress Levels in Surgical Training. Annals of Surgery. 269(5). 810–811. 1 indexed citations
7.
Potus, François, Grégoire Ruffenach, Abdellaziz Dahou, et al.. (2015). Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. 132(10). 932–943. 168 indexed citations
8.
Potus, François, Simon Malenfant, Colin Graydon, et al.. (2014). Impaired Angiogenesis and Peripheral Muscle Microcirculation Loss Contribute to Exercise Intolerance in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 190(3). 318–328. 103 indexed citations
9.
Potus, François, Colin Graydon, Steeve Provencher, & Sébastien Bonnet. (2014). Vascular Remodeling Process in Pulmonary Arterial Hypertension, with Focus on miR‐204 and miR‐126 (2013 Grover Conference Series). Pulmonary Circulation. 4(2). 175–184. 42 indexed citations
10.
Potus, François, Colin Graydon, Sandra Breuils Bonnet, et al.. (2014). Mir‐126 dependent alteration of angiogenesis contributes to right ventricle failure in pulmonary arterial hypertension (868.2). The FASEB Journal. 28(S1). 1 indexed citations
11.
Meloche, Jolyane, Aude Pflieger, Mylène Vaillancourt, et al.. (2014). miRNAs in PAH: biomarker, therapeutic target or both?. Drug Discovery Today. 19(8). 1264–1269. 23 indexed citations
12.
Meloche, Jolyane, Aude Pflieger, Mylène Vaillancourt, et al.. (2013). Role for DNA Damage Signaling in Pulmonary Arterial Hypertension. Circulation. 129(7). 786–797. 198 indexed citations
13.
Hirota, Jeremy A., Paul Hiebert, Dan Wu, et al.. (2013). Granzyme B Deficiency Exacerbates Lung Inflammation in Mice after Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 49(3). 453–462. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026